Tahoe Therapeutics

Tahoe | Accelerating Biological Superintelligence

Tahoe Therapeutics was founded in 2022, is headquartered in South San Francisco, United States, lists 11–50 employees, and has $42.0M in recorded funding across 2 rounds.

Employees
11–50
Founded
2022
Business Model
B2B
Total Funding
$42.0M
Last Round
$30.0M Venture RoundAug 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.

About

Tahoe Therapeutics (formerly Vevo Therapeutics) is an AI-enabled biotechnology company building virtual models of the human cell to design better drugs. The company generates hundreds of millions of single-cell data points through its proprietary platform, mapping how drug molecules interact with patient biology. Its gigascale, perturbative single-cell maps and the AI models trained on them have enabled novel therapeutic discoveries in cancer. Founded in 2022, Tahoe is based in South San Francisco, California, and has raised $30M to build the world's largest dataset for training AI models of human cells. The company collaborates with NVIDIA, the Arc Institute, and Biohub, and has open-sourced its Tahoe-100M dataset.

Summary

Tahoe Therapeutics is a Life Sciences company based in South San Francisco, United States, founded in 2022. It lists 11–50 employees. It has raised $42.0M in total across 2 rounds, most recently a $30.0M Venture Round in Aug 2025. Investors include Amplify Partners, Wing VC and General Catalyst.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundAug 2025
$30.0M

Sign up to see all 2 events

Funding: Seed through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Tahoe Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/tahoe"><img src="https://indexed.vc/api/badge/company/tahoe" alt="Tahoe Therapeutics on Indexed.vc" width="260" height="76" /></a>